Literature DB >> 7014624

Evaluation of five gentamicin assay procedures for clinical microbiology laboratories.

S T Selepak, F G Witebsky, E A Robertson, J D MacLowry.   

Abstract

Five gentamicin assay procedures (a bioassay, an enzyme immunoassay, a latex agglutination inhibition test, a fluorescence immunoassay, and a radioimmunoassay) were evaluated to determine which was optimal for our laboratory. The evaluation was based on recovery and precision studies and results of analyses of patient samples, as well as technical assay performance factors. The latex agglutination inhibition test appears useful for laboratories performing only occasional assays for gentamicin; however, the fact that some rheumatoid factor-positive sera, as well as some other sera for unknown reasons, may give falsely low values is a potential drawback to this procedure. Because of its accuracy, precision, rapid turn-around time, and relative simplicity of performance, we selected the enzyme immunoassay procedure for routine use for gentamicin assays in our laboratory.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7014624      PMCID: PMC273871          DOI: 10.1128/jcm.13.4.742-749.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  4 in total

1.  Use and interpretation of common statistical tests in method-comparison studies.

Authors:  J O Westgard; M R Hunt
Journal:  Clin Chem       Date:  1973-01       Impact factor: 8.327

2.  Rapid, reproducible enzyme immunoassay for gentamicin.

Authors:  D Phaneuf; E Francke; H C Neu
Journal:  J Clin Microbiol       Date:  1980-03       Impact factor: 5.948

3.  Evaluation of an enzyme immunoassay for serum gentamicin.

Authors:  T D O'Leary; R M Ratcliff; T D Geary
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

4.  Evaluation of serum gentamicin assay procedures for a clinical microbiology laboratory.

Authors:  C H Lantz; D J Lawrie; F G Witebsky; J D MacLowry
Journal:  J Clin Microbiol       Date:  1980-10       Impact factor: 5.948

  4 in total
  8 in total

1.  Evaluation of four gentamicin and tobramycin assay procedures for clinical laboratories.

Authors:  F G Witebsky; C A Sliva; S T Selepak; M E Ruddel; J D MacLowry; E E Johnson; R J Elin
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

2.  An evaluation of gentamicin EMIT--its performance on the Kem-O-Mat and its role in the small laboratory.

Authors:  R G Masterton; R E Tettmar; P W Strike; S Williams
Journal:  J Clin Pathol       Date:  1983-11       Impact factor: 3.411

3.  Serum assays of netilmicin by enzyme multiplied immunoassay technique and bioassay: a comparative study.

Authors:  L Jansson; C Henning
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

4.  Comparison of a simplified liquid chromatographic assay of gentamicin in serum with enzyme immunoassay and bioassay.

Authors:  L Essers
Journal:  Eur J Clin Microbiol       Date:  1982-12       Impact factor: 3.267

5.  Assay of netilmicin, using enzyme immunoassay for gentamicin.

Authors:  T Larson; D N Gerding; L R Peterson; J H Eckfeldt
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

6.  Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium.

Authors:  F Caron; M D Kitzis; L Gutmann; A C Cremieux; B Maziere; J M Vallois; A Saleh-Mghir; J F Lemeland; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

7.  Evaluation of the macro-vue latex agglutination test for quantitation of gentamicin in human serum.

Authors:  J E Johnson; S Crawford; J H Jorgensen
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

8.  Radioenzymatic assays for aminoglycosides with kanamycin 6'-acetyltransferase.

Authors:  A Weber; A L Smith; K E Opheim
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.